Accelerate Diagnostics, Inc. (0H8E.L)
USD 0.57
(-14.24%)
USD 0.57
(-14.24%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 51.25 Million USD | -41.28% |
| 2022 | 87.27 Million USD | -26.11% |
| 2021 | 118.11 Million USD | -28.07% |
| 2020 | 164.21 Million USD | 15.8% |
| 2019 | 141.8 Million USD | 10.88% |
| 2018 | 127.89 Million USD | 1778.53% |
| 2017 | 6.8 Million USD | 35.19% |
| 2016 | 5.03 Million USD | -20.14% |
| 2015 | 6.3 Million USD | 65.51% |
| 2014 | 3.81 Million USD | 235.09% |
| 2013 | 1.13 Million USD | -8.9% |
| 2012 | 1.24 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 56.5 Million USD | 10.24% |
| 2024 Q2 | 57.75 Million USD | 2.22% |
| 2023 FY | 51.25 Million USD | -41.28% |
| 2023 Q4 | 51.25 Million USD | -31.07% |
| 2023 Q3 | 74.35 Million USD | -16.02% |
| 2023 Q1 | 89.72 Million USD | 2.8% |
| 2023 Q2 | 88.54 Million USD | -1.32% |
| 2022 Q4 | 87.27 Million USD | 1.68% |
| 2022 Q1 | 126.41 Million USD | 7.02% |
| 2022 Q2 | 120.69 Million USD | -4.53% |
| 2022 Q3 | 85.83 Million USD | -28.88% |
| 2022 FY | 87.27 Million USD | -26.11% |
| 2021 FY | 118.11 Million USD | -28.07% |
| 2021 Q1 | 159.03 Million USD | 1.79% |
| 2021 Q2 | 163.73 Million USD | 2.96% |
| 2021 Q3 | 120.9 Million USD | -26.16% |
| 2021 Q4 | 118.11 Million USD | -2.31% |
| 2020 Q2 | 151.8 Million USD | 6.21% |
| 2020 Q1 | 142.93 Million USD | 0.8% |
| 2020 Q3 | 153.88 Million USD | 1.37% |
| 2020 Q4 | 156.23 Million USD | 1.53% |
| 2020 FY | 164.21 Million USD | 15.8% |
| 2019 Q1 | 129.21 Million USD | 1.04% |
| 2019 Q4 | 141.8 Million USD | 3.46% |
| 2019 FY | 141.8 Million USD | 10.88% |
| 2019 Q3 | 137.05 Million USD | 3.33% |
| 2019 Q2 | 132.63 Million USD | 2.65% |
| 2018 FY | 127.89 Million USD | 1778.53% |
| 2018 Q4 | 127.89 Million USD | 3.76% |
| 2018 Q3 | 123.25 Million USD | -0.09% |
| 2018 Q2 | 123.36 Million USD | 15.69% |
| 2018 Q1 | 106.64 Million USD | 1471.24% |
| 2017 FY | 6.8 Million USD | 35.19% |
| 2017 Q3 | 6.18 Million USD | -0.64% |
| 2017 Q1 | 5.24 Million USD | 30.05% |
| 2017 Q4 | 6.78 Million USD | 9.77% |
| 2017 Q2 | 6.22 Million USD | 18.56% |
| 2016 Q1 | 4.98 Million USD | -6.01% |
| 2016 FY | 5.03 Million USD | -20.14% |
| 2016 Q4 | 4.03 Million USD | -9.28% |
| 2016 Q3 | 4.44 Million USD | -0.56% |
| 2016 Q2 | 4.47 Million USD | -10.29% |
| 2015 Q2 | 2.99 Million USD | -14.4% |
| 2015 Q1 | 3.5 Million USD | -8.11% |
| 2015 FY | 6.3 Million USD | 65.51% |
| 2015 Q4 | 5.3 Million USD | 48.71% |
| 2015 Q3 | 3.56 Million USD | 19.05% |
| 2014 Q1 | 2.6 Million USD | 129.38% |
| 2014 Q4 | 3.81 Million USD | 32.48% |
| 2014 FY | 3.81 Million USD | 235.09% |
| 2014 Q3 | 2.87 Million USD | -7.23% |
| 2014 Q2 | 3.1 Million USD | 18.87% |
| 2013 Q4 | 1.13 Million USD | 176.01% |
| 2013 Q2 | 1.8 Million USD | 59.08% |
| 2013 Q1 | 1.13 Million USD | -8.98% |
| 2013 FY | 1.13 Million USD | -8.9% |
| 2013 Q3 | 411.94 Thousand USD | -77.21% |
| 2012 FY | 1.24 Million USD | 0.0% |
| 2012 Q4 | 1.24 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| QuidelOrtho Corporation | 3.55 Billion USD | 98.559% |